Second annual University of Washington Biomedical Technology Conference
Subtitle: June 3, 1994, Washington State Convention and Trade Center, Seattle, Washington
By: co-sponsored by the Washington Law School Foundation and the Washington Biotechnology & Biomedical Association, with support from the law firm of Heller Ehrman White & McAuliffe.
Contributors: Washington Law School Foundation.; Washington Biotechnology & Biomedical Association.
Publisher: The Foundation
Published: 1994
Place of publication: [Seattle, Wash.]
Language: eng
Subjects: Biotechnology industries -- United States -- Congresses.; Biotechnology -- United States -- Congresses.; Biotechnology -- Research -- Law and legislation -- United States -- Congresses.
Table of contents: value: International regulation of biomedical products /Patrick Doolan; value: The impact of securities law on biomedical companies / Douglas Schwab, George E. Greer; value: National Institutes of Health role in promoting biotechnology / Marvin Cassman; value: Clinical trials; value: medical malpractice and tort liability issues /William J. Downey III; value: Current developments and regulatory initiatives at the Center for Biologics Evaluation and Research, FDA / Michael Beatrice; value: International patents / William M. Smith, Vern Norviel; value: Biotechnology in the information age /Gregory C. Simon; value: Corporate collaborations / Rick Fox, Louis A. Bianco, Alan Frazier, Michael Kranda, Kurt Wheeler.